-
Legendary Scientist and Biotech Veteran Joins CancerVax as Strategic Advisor
03 Sep 2025 07:01 GMT
… , a clinical phase cancer biotech company developing a … and Scientific Director of Affymax Research Institute (acquired by … , Santa Cruz, 1972. CancerVax Chief Scientific Officer, Dr. … 47;/cancervax.com/explainer About CancerVax CancerVax is a …
-
Affymax and Takeda Announce a Nationwide Voluntary Recall of All Lots of OMONTYS® (peginesatide) Injection
26 Feb 2013 12:04 GMT
… ESAs in patients with cancer, increased risk for death … recurrence in patients with cancer receiving ESAs.In controlled … patients receiving treatment for cancer and whose anemia is … information on Affymax, please visit www.affymax.com.Affymax Forward-Looking …
-
People on the Move 9-15-25
13 Sep 2025 21:25 GMT
… and supply chain performance.
• CancerVax Inc., a Lehi-based … BioSciences, a clinical phase cancer biotech company, and founder … and scientific director of Affymax Research Institute (acquired by … of the Institute for Cancer and Developmental Biology at …
-
Supercharging conventional monoclonal antibodies
29 Jul 2024 09:08 GMT
… mechanism of action for treating cancer and autoimmune diseases?
Commit’s … -class therapeutics for patients with cancer and autoimmune diseases?
The BiCE … Equillium, Raptor Pharmaceuticals, CytomX Therapeutics, Affymax, and Amgen. Most recently, Krishna …